45P Long-term efficacy of neratinib in HER2-positive early-stage breast cancer: Overall survival and central nervous system outcomes from the phase III ExteNET trial
Title:
45P Long-term efficacy of neratinib in HER2-positive early-stage breast cancer: Overall survival and central nervous system outcomes from the phase III ExteNET trial
Author:
Chan, A. Moy, B. Mansi, J.L. Gnant, M.I. Barrios, C.H. Separovic, R. Guerrero-Zotano, A. Gore, I. Smith, J. Bryce, R.P. Xu, F. Wong, A. Martin, M. Holmes, F.A.